Polygiene Group AB
SSE:POLYG.ST
6.83 (SEK) • At close February 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 113.542 | 173.564 | 181.61 | 83.932 | 68.803 | 69.039 | 75.68 | 61.557 | 51.511 | 34.957 | 27.804 | 18.641 |
| Cost of Revenue
| 73.561 | 58.991 | 66.368 | 27.399 | 21.039 | 23.717 | 33.045 | 26.049 | 29.609 | 13.496 | 11.116 | 8.073 |
| Gross Profit
| 39.981 | 114.573 | 115.242 | 56.533 | 47.764 | 45.322 | 42.635 | 35.508 | 21.902 | 21.461 | 16.688 | 10.568 |
| Gross Profit Ratio
| 0.352 | 0.66 | 0.635 | 0.674 | 0.694 | 0.656 | 0.563 | 0.577 | 0.425 | 0.614 | 0.6 | 0.567 |
| Reseach & Development Expenses
| 1.59 | 1.247 | 0 | 0 | 2.9 | 2.5 | 1.1 | 1.1 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 48.035 | 45.703 | 43.535 | 37.064 | 37.74 | 35.077 | 30.59 | 28.313 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 6.7 | 9.5 | 6.9 | 4.6 | 5.9 | 0 | 11.4 | 9.6 | 0 | 0 | 0 | 0 |
| SG&A
| 54.735 | 55.203 | 43.535 | 37.064 | 37.74 | 35.077 | 30.59 | 28.313 | 15.611 | 18.465 | 15.113 | 14.406 |
| Other Expenses
| 0 | 98.581 | 30.849 | 20.52 | 16.595 | 13.05 | 15.809 | 12.551 | 45.912 | 31.282 | 26.391 | 0 |
| Operating Expenses
| 56.325 | 98.581 | 74.384 | 57.584 | 54.335 | 48.127 | 46.399 | 40.864 | 45.912 | 31.282 | 26.391 | 14.68 |
| Operating Income
| -16.344 | 15.992 | 40.858 | 0.114 | -6.571 | -2.805 | -6.101 | -3.392 | 5.599 | 3.675 | 1.413 | -4.113 |
| Operating Income Ratio
| -0.144 | 0.092 | 0.225 | 0.001 | -0.096 | -0.041 | -0.081 | -0.055 | 0.109 | 0.105 | 0.051 | -0.221 |
| Total Other Income Expenses Net
| -296.731 | -0.035 | -0.391 | -1.2 | -0.052 | -0.002 | -2.345 | 1.959 | 0.042 | 0.008 | 0.005 | -0 |
| Income Before Tax
| -313.075 | 15.957 | 40.467 | -1.086 | -6.623 | -2.807 | -6.109 | -3.397 | 5.641 | 3.683 | 1.418 | -4.113 |
| Income Before Tax Ratio
| -2.757 | 0.092 | 0.223 | -0.013 | -0.096 | -0.041 | -0.081 | -0.055 | 0.11 | 0.105 | 0.051 | -0.221 |
| Income Tax Expense
| 8.873 | 7.599 | 7.642 | 0.65 | -1.452 | 1.874 | -0.7 | -0.233 | -3.53 | -1.76 | 1.413 | -0 |
| Net Income
| -321.948 | 8.358 | 32.825 | -1.736 | -5.171 | 5.907 | -5.409 | -3.164 | 9.171 | 5.443 | 1.418 | -4.113 |
| Net Income Ratio
| -2.835 | 0.048 | 0.181 | -0.021 | -0.075 | 0.086 | -0.071 | -0.051 | 0.178 | 0.156 | 0.051 | -0.221 |
| EPS
| -8.81 | 0.23 | 0.92 | -0.085 | -0.25 | 0.29 | -0.26 | -0.16 | 0.47 | 0.28 | 0.073 | -0.26 |
| EPS Diluted
| -8.81 | 0.22 | 0.92 | -0.085 | -0.25 | 0.29 | -0.26 | -0.15 | 0.47 | 0.28 | 0.073 | -0.26 |
| EBITDA
| -12.549 | 20.345 | 43.992 | 0.701 | -5.379 | -2.007 | -5.915 | -3.392 | 5.599 | 3.675 | 1.413 | -0 |
| EBITDA Ratio
| -0.111 | 0.117 | 0.242 | 0.008 | -0.078 | -0.029 | -0.078 | -0.055 | 0.109 | 0.105 | 0.051 | -0 |